When Will Mounjaro Be Available on the NHS?

Mounjaro is a prescription-only medicine containing tirzepatide, a dual GIP and GLP-1 receptor agonist used in the management of weight in adults. Whether it is available through a publicly funded healthcare scheme — and under what conditions — is decided separately in each country and, in some cases, each region.

In England, NHS guidance on weight-management medicines has been developed through bodies such as NICE (the National Institute for Health and Care Excellence), which issues technology appraisals that determine when a medicine can be prescribed on the NHS and in what care settings. These pathways often phase in over time: a medicine approved for NHS use may initially be available only through specialist weight-management services before becoming more widely accessible in primary care.

It is worth noting that healthcare commissioning decisions are not static — they are updated as clinical evidence grows, as capacity in specialist services expands, and as national guidance is revised. This means the answer to "when will Mounjaro be available on the NHS?" is genuinely subject to change, and checking with your prescriber or doctor, or looking at the latest guidance from your relevant national health authority, will give you the most current picture.

For those outside the UK, publicly funded access to weight-loss medicines like Mounjaro will depend entirely on your own country's healthcare system and its current guidance. There is no single worldwide answer.

For more on how access and cost factors relate to Mounjaro, see our overview of Mounjaro cost and value considerations. You may also find it helpful to read about Mounjaro on the NHS: what the guidance says, or, if you are curious about a similar medicine, when Wegovy may be available on the NHS.

Whatever route you took to get your prescription — whether privately or through a publicly funded programme — what matters most once you are on Mounjaro is staying consistent and making the most of every week of treatment.

That is exactly where GLP Trackr is built to help. The app's dose and injection logging feature lets you record every weekly shot — the date, dose strength, and injection site — so you always have a clear record of where you are in your treatment. If you ever need to discuss your progress with your prescriber, that history is already there, organised and easy to share.

Alongside dose tracking, GLP Trackr's progress and insight tools help you see your journey clearly over time — weight trends, energy, mood, and how your body is responding week by week. The app also includes a community of people on the same path, so you do not have to figure things out alone.

GLP Trackr does not sell, supply, or source Mounjaro or any other medicine. For questions about obtaining a prescription or understanding what is available in your area, your prescriber or doctor is the right person to speak to — they can advise based on your circumstances and the current guidance where you live.

If you want to read more about how access works in specific contexts, our page on Mounjaro and NHS availability covers the topic in more detail.

Ready to make your Mounjaro journey easier to manage? Download GLP Trackr free on the App Store or Google Play — your first 7 days are on us.